1. Du, Bingxin, Jia, Xinhui, Tian, Wenqi, Qiu, Changchun, Zhang, Qi. 2020. Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population. In Journal of diabetes and its complications, 35, 107752. doi:10.1016/j.jdiacomp.2020.107752. https://pubmed.ncbi.nlm.nih.gov/33127268/
2. Volpin, Valentina, Michels, Tillmann, Sorrentino, Antonio, Khandelwal, Nisit, Beckhove, Philipp. 2020. CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment. In Cancer immunology research, 8, 1163-1179. doi:10.1158/2326-6066.CIR-19-0608. https://pubmed.ncbi.nlm.nih.gov/32665263/
3. Bergamaschi, Anna, Kim, Young H, Kwei, Kevin A, Børresen-Dale, Anne-Lise, Pollack, Jonathan R. 2008. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. In Molecular oncology, 2, 327-39. doi:10.1016/j.molonc.2008.09.004. https://pubmed.ncbi.nlm.nih.gov/19383354/
4. Yao, Chi-Yuan, Lin, Chien-Chin, Wang, Yu-Hung, Hsu, Chia-Lang, Chou, Wen-Chien. . Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. In Blood advances, 8, 2442-2454. doi:10.1182/bloodadvances.2023011512. https://pubmed.ncbi.nlm.nih.gov/38527292/
智鼠故事 
